{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:20:59Z","timestamp":1778800859029,"version":"3.51.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>Distinguishing endometrial hyperplasia from endometrial adenocarcinoma remains a histopathologic challenge. Several retrospective studies have reported high interobserver variability when assessing the progestin-naive endometrium, while only one study has assessed interobserver variability of postprogestin endometrial biopsies. This study quantified the interobserver variability between trial site pathologists and central pathology review of endometrial specimens taken before treatment with the levonorgestrel intrauterine device (LNG-IUD), 3 months and 6 months post-treatment as part of the feMMe phase 2 randomized clinical trial (NCT01686126). Interobserver agreement was 73% (105\/143, \u03ba=0.50) at baseline, 80% (107\/134, \u03ba=0.72) at 3 months and 77% (98\/127, \u03ba=0.64) at 6 months post-LNG-IUD treatment. Overall, 42% (45\/107) site-reported diagnoses of endometrial hyperplasia and 13% (21\/161) site-reported diagnoses of endometrial adenocarcinoma were discordant. Site-reported diagnoses were upgraded to higher risk pathology on central review for 77% (72\/94) discordant cases. This study confirms the high rate of interobserver variability when diagnosing endometrial hyperplasia or endometrial adenocarcinoma both before and after progestin treatment in specimens collected as part of a clinical trial. It emphasizes the value of confirming diagnosis by a gynecologic pathologist and comparing specimens from the progestin-treated endometrium with the pretreatment biopsy. This study highlights the importance of central pathology review for clinical trial reporting and when deciding on treatment options and assessing response, particularly in the context of progestin treatment.<\/jats:p>","DOI":"10.1097\/pas.0000000000002492","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:00:15Z","timestamp":1764046815000},"page":"259-266","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Central Pathology Review of Endometrial Hyperplasia and Adenocarcinoma Before and After Treatment With the Levonorgestrel Intrauterine Device\u2013Results From the feMMe Phase 2 Randomized Clinical Trial"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7685-8036","authenticated-orcid":false,"given":"Eva","family":"Baxter","sequence":"first","affiliation":[{"name":"Queensland Centre for Gynaecological Cancer Research, The University of Queensland, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristy P.","family":"Robledo","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Cummings","sequence":"additional","affiliation":[{"name":"Pathology Queensland, Royal Brisbane and Women\u2019s Hospital, Brisbane, Australia"},{"name":"UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Alizart","sequence":"additional","affiliation":[{"name":"Sullivan Nicolaides Pathology, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Smith","sequence":"additional","affiliation":[{"name":"Pathology Queensland, Royal Brisbane and Women\u2019s Hospital, Brisbane, Australia"},{"name":"The University of Queensland, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Obermair","sequence":"additional","affiliation":[{"name":"Queensland Centre for Gynaecological Cancer Research, The University of Queensland, Brisbane, Australia"},{"name":"Department of Obstetrics and Gynaecology, Royal Brisbane and Women\u2019s Hospital, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"R1-20260113","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R3-20260113","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/ijgc-2022-004047","article-title":"ESGO\/ESHRE\/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma","volume":"33","author":"Rodolakis","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"R4-20260113","doi-asserted-by":"crossref","first-page":"191.e1","DOI":"10.1016\/j.ajog.2020.08.032","article-title":"Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer","volume":"224","author":"Westin","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20260113","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2021.01.029","article-title":"Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: results of a randomized clinical trial","volume":"161","author":"Janda","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R6-20260113","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/PAS.0b013e318159a2a0","article-title":"Diagnosing endometrial hyperplasia: why is it so difficult to agree?","volume":"32","author":"Allison","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R7-20260113","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/IGC.0000000000000870","article-title":"Second opinion expert pathology in endometrial cancer: potential clinical implications","volume":"27","author":"Grevenkamp","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"R8-20260113","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199909000-00014","article-title":"A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens","volume":"23","author":"Bergeron","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R9-20260113","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/cncr.21649","article-title":"Reproducibility of the diagnosis of atypical endometrial hyperplasia","volume":"106","author":"Zaino","year":"2006","journal-title":"Cancer"},{"key":"R10-20260113","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/PGP.0b013e3181659167","article-title":"Reproducibility of biopsy diagnoses of endometrial hyperplasia: evidence supporting a simplified classification","volume":"27","author":"Sherman","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R11-20260113","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00000478-199808000-00012","article-title":"Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma","volume":"22","author":"Kendall","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R12-20260113","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/his.12249","article-title":"Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classification","volume":"64","author":"Ordi","year":"2014","journal-title":"Histopathology"},{"key":"R13-20260113","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/PGP.0000000000000791","article-title":"Survey on reporting of endometrial biopsies from women on progestogen therapy for endometrial atypical hyperplasia\/endometrioid carcinoma","volume":"41","author":"Ganesan","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R14-20260113","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cct.2014.06.014","article-title":"Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device\u00b1Metformin\u00b1weight loss in endometrial cancer (feMME) trial","volume":"39","author":"Hawkes","year":"2014","journal-title":"Contemp Clin Trials"},{"key":"R15-20260113","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"key":"R16-20260113","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/annonc\/mdx753","article-title":"Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer","volume":"29","author":"de Boer","year":"2018","journal-title":"Ann Oncol"},{"key":"R17-20260113","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2005.03.007","article-title":"Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review","volume":"63","author":"Scholten","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-20260113","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jmig.2016.03.017","article-title":"Sampling in atypical endometrial hyperplasia: which method results in the lowest underestimation of endometrial cancer? A systematic review and meta-analysis","volume":"23","author":"Bourdel","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"key":"R19-20260113","doi-asserted-by":"crossref","first-page":"103","DOI":"10.52054\/FVVO.14.2.023","article-title":"Endometrial biopsy under direct hysteroscopic visualisation versus blind endometrial sampling for the diagnosis of endometrial hyperplasia and cancer: systematic review and meta-analysis","volume":"14","author":"Di Spiezio Sardo","year":"2022","journal-title":"Facts Views Vis Obgyn"},{"issue":"suppl 1","key":"R24-20260113","doi-asserted-by":"crossref","first-page":"s25","DOI":"10.1097\/PGP.0000000000000512","article-title":"Issues in the differential diagnosis of uterine low-grade endometrioid carcinoma, including mixed endometrial carcinomas: recommendations from the International Society of Gynecological Pathologists","volume":"38 Suppl 1","author":"Rabban","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R25-20260113","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/1066896906299120","article-title":"Morphologic changes in the endometrium associated with the use of the Mirena coil: a retrospective study of 106 cases","volume":"15","author":"Hejmadi","year":"2007","journal-title":"Int J Surg Pathol"},{"key":"R26-20260113","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/jcp.56.4.305","article-title":"The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology","volume":"56","author":"Phillips","year":"2003","journal-title":"J Clin Pathol"},{"key":"R27-20260113","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/PGP.0000000000000183","article-title":"Endometrial synovial-like metaplasia associated with levonorgestrel-releasing intrauterine system","volume":"34","author":"Stewart","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R28-20260113","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1309\/AJCPM2TSDDF1MHBZ","article-title":"Assessing endometrial hyperplasia and carcinoma treated with progestin therapy","volume":"138","author":"Mentrikoski","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R29-20260113","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/PAS.0b013e31802d68ce","article-title":"Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins","volume":"31","author":"Wheeler","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R30-20260113","doi-asserted-by":"crossref","first-page":"e0302252","DOI":"10.1371\/journal.pone.0302252","article-title":"Factors associated with interobserver variation amongst pathologists in the diagnosis of endometrial hyperplasia: a systematic review","volume":"19","author":"McCoy","year":"2024","journal-title":"PLoS One"},{"key":"R31-20260113","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/PAS.0000000000001810","article-title":"Reliable identification of endometrial precancers through combined Pax2, \u03b2-catenin, and Pten immunohistochemistry","volume":"46","author":"Aguilar","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R32-20260113","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/PAS.0000000000002034","article-title":"\u03b2-catenin, Pax2, and Pten panel identifies precancers among histologically subdiagnostic endometrial lesions","volume":"47","author":"Aguilar","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R33-20260113","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/his.15215","article-title":"Lesions sub-diagnostic of endometrioid intra-epithelial neoplasia\/atypical hyperplasia: value of morphology and immunohistochemistry in predicting neoplastic outcome","volume":"85","author":"Wyvekens","year":"2024","journal-title":"Histopathology"},{"key":"R34-20260113","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0000000000001537","article-title":"Specific biomarker expression patterns in the diagnosis of residual and recurrent endometrial precancers after progestin treatment: a longitudinal study","volume":"44","author":"Chen","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R35-20260113","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PGP.0000000000000615","article-title":"A new classification of benign, premalignant, and malignant endometrial tissues using machine learning applied to 1413 candidate variables","volume":"39","author":"Downing","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R36-20260113","doi-asserted-by":"crossref","first-page":"100417","DOI":"10.1016\/j.modpat.2023.100417","article-title":"Endometrial pipelle biopsy computer-aided diagnosis: a feasibility study","volume":"37","author":"Vermorgen","year":"2024","journal-title":"Mod Pathol"},{"key":"R37-20260113","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/path.5586","article-title":"Computational augmentation of neoplastic endometrial glands in digital pathology displays","volume":"253","author":"Papke","year":"2021","journal-title":"J Pathol"},{"key":"R38-20260113","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1109\/JBHI.2019.2944977","article-title":"Computer-aided diagnosis in histopathological images of the endometrium using a convolutional neural network and attention mechanisms","volume":"24","author":"Sun","year":"2020","journal-title":"IEEE J Biomed Health Inform"},{"key":"R39-20260113","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2011.11.004","article-title":"Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy","volume":"124","author":"Penner","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R40-20260113","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","article-title":"Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy","volume":"119","author":"Wortman","year":"2018","journal-title":"Br J Cancer"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:00:12Z","timestamp":1768284012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002492","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]}}}